Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Guanglin Zhou
Introduction
Guanglin Zhou is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of pharmaceuticals through his innovative work. His research focuses on developing treatments for various diseases related to the dysregulation of kinases.
Latest Patents
Guanglin Zhou holds a patent for a process related to the manufacture of (S)-N-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)-5-methoxypyrimidin-4-yl)oxy)phenyl)acrylamide. This invention pertains to solid forms of certain N-(pyrimidinyloxy)acrylamide derivatives. These derivatives are useful in treating proliferation and immunological disorders, as well as other diseases linked to kinase dysregulation, including EGFR, Alk, and JAK kinases. The patent also provides methods for making these materials, their salts, polymorphs, and pharmaceutical compositions that include them.
Career Highlights
Guanglin Zhou is currently associated with Acea Therapeutics, Inc., where he continues to advance his research and development efforts. His work has the potential to impact the treatment of various conditions, including tumors, inflammatory diseases, autoimmune diseases, and more.
Collaborations
Guanglin Zhou collaborates with talented individuals such as Long Mao and Jia Liu. Their combined expertise contributes to the innovative environment at Acea Therapeutics, Inc.
Conclusion
Guanglin Zhou's contributions to the field of pharmaceuticals through his patent and collaborative efforts highlight his role as an influential inventor. His work aims to provide effective treatments for serious health conditions, showcasing the importance of innovation in medical research.